3 h. ago Chinese vessel grounding: concern in Philippines over new grey

A recent case of a Chinese militia vessel running aground on a strategic island in the disputed South China Sea has raised concerns from the Philippine side of another wave of so-called grey-zone activities by Beijing, even as Manila’s officials acknowledge the incident could be down to inclement weather. Observers point to the Philippines having adopted the same strategy to stake claim over the Second Thomas Shoal when it permanently grounded the war vessel BRP Sierra Madre in 1999. The recent...

Politics

37 h. ago Two Chinese Aircraft Carriers Are Operating Beyond The First Island Chain For The First Time

Two Chinese Aircraft Carriers Are Operating Beyond The First Island Chain For The First Time  The War Zone

Transport

3 d. ago Chinese Aircraft Carrier Breaches Pacific Island Defense Line

Chinese Aircraft Carrier Breaches Pacific Island Defense Line  Newsweek

Events

6 d. ago China Becomes Source of New Cancer Treatments, in Threat to U.S. Drug Development

China Becomes Source of New Cancer Treatments, in Threat to U.S. Drug Development  Barron's

Events

2 w. ago Cancer drug trials in China’s Hainan, world’s fastest coilgun: 5 weekend reads

Cancer drug trials in China’s Hainan, world’s fastest coilgun: 5 weekend reads  South China Morning Post

Events

2 w. ago On this Chinese island, patients are trying latest experimental drugs for cancer

A medical revolution quietly unfolds on Hainan, allowing patients to access cutting-edge therapies before they hit the market.

Events

3 w. ago Chinese biotech firm secures US$6 billion Pfizer deal for cancer drug

Pfizer will produce the drug, which targets lung and colorectal cancers, in the US and take a US$100 million stake in China’s 3SBio.

Economics

3 w. ago Chinese biotech firm secures Pfizer deal despite trade tensions

Chinese drug maker 3SBio has licensed its new cancer drug to US pharmaceutical giant Pfizer in the largest deal ever for China’s biotech industry, underscoring the strong commercial Sino-US ties despite geopolitical headwinds. Based in Shenyang, capital of northeastern Liaoning province, 3SBio will receive a US$1.25 billion upfront payment for licensing its cancer drug SSGJ-707 exclusively to Pfizer, which will manufacture and commercialise the drug outside mainland China, the companies...

Economics

3 w. ago Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China

Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China  Investopedia

Economics

3 w. ago Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stake

Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stake  Reuters

Events

3 w. ago Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug

Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug  Reuters

Economics

3 w. ago Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug

Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug  Reuters

Economics

3 w. ago US Ally Intercepts Chinese Fleet Breaching Pacific Island Chain

US Ally Intercepts Chinese Fleet Breaching Pacific Island Chain  Newsweek

Politics

3 w. ago Mainland Chinese drug effective in treating 3 cancer types: Hong Kong

CUHK researchers say drug D3S-001 can treat non-small-cell lung, colorectal and pancreatic cancers triggered by gene mutation KRAS-G12C.

Events